{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T17:54:12Z","timestamp":1791914052164,"version":"4.3.4"},"reference-count":141,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:00:00Z","timestamp":1791849600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Chromoblastomycosis (CBM) is a chronic implantation mycosis of considerable morbidity, first described more than a century ago, predominantly affecting rural populations in tropical and subtropical regions. Although historically associated with impoverished settings, an increasing number of cases have been reported in both endemic and non-endemic areas, including high-income countries, reflecting an underrecognized epidemiological landscape. Despite its burden, key metrics such as disability-adjusted life years (DALYs) remain undefined, as highlighted by recent global health initiatives. While advances in diagnosing and treating patients with CBM have been made, new technologies have not been incorporated into broader clinical and public health interventions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methodology\/principal findings<\/jats:title>\n                    <jats:p>Herein, we synthesize recent advances in CBM, focusing on the expanding biodiversity of etiological agents driven by molecular taxonomy, the growing role of molecular diagnostics, and emerging therapeutic strategies. Novel genera and species have been identified, particularly among immunocompromised hosts, reshaping our understanding of host\u2013pathogen interactions. Molecular tools, including PCR-based and genomic approaches, have improved species-level identification, although their availability remains largely restricted to reference centers. Therapeutically, extended-spectrum triazoles and terbinafine have shown the most consistent activity, while adjunctive immunomodulatory strategies, such as imiquimod, are emerging as promising alternatives.<\/jats:p>\n                    <jats:p>However, these advances sharply contrast with real-world clinical practice. In endemic settings, diagnosis continues to rely on low-cost conventional methods, which, given their sensitivity, should be more widely incorporated into public health screening and active case-finding strategies. Antifungal susceptibility testing lacks clear clinical correlation, and treatment decisions remain largely based on observational studies, in the absence of randomized controlled trials.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Conclusions and significance<\/jats:title>\n                    <jats:p>CBM exemplifies a neglected tropical disease in which substantial progress in basic science has not translated into improved patient outcomes. Strengthening public health strategies, expanding access to simple and effective diagnostic tools, and prioritizing implementation-focused research are urgently needed to bridge this persistent gap.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pntd.0014801","type":"journal-article","created":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T17:33:04Z","timestamp":1791912784000},"page":"e0014801","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["From molecular advances to limited clinical impact: The persistent gap in chromoblastomycosis"],"prefix":"10.1371","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4946-911X","authenticated-orcid":true,"given":"Daniel Wagner C. L.","family":"Santos","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases of Hospital Universit\u00e1rio Presidente Dutra da Universidade Federal do Maranh\u00e3o (UFMA), Ebserh","place":["S\u00e3o Lu\u00eds, Maranh\u00e3o, Brazil"]},{"name":"Instituto D\u2019Or de Pesquisa e Ensino, IDOR","place":["S\u00e3o Paulo, Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dallas J.","family":"Smith","sequence":"additional","affiliation":[{"name":"Mycotic Diseases Branch, Centers for Disease Control and Prevention","place":["Atlanta, Georgia, United States of America"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vania Aparecida","family":"Vicente","sequence":"additional","affiliation":[{"name":"Federal University of Paran\u00e1","place":["Curitiba, Brazil"],"department":["Microbiology, Parasitology, and Pathology Post Graduation Program, Department of Pathology"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno Paulo Rodrigues","family":"Lustosa","sequence":"additional","affiliation":[{"name":"Federal University of Paran\u00e1","place":["Curitiba, Brazil"],"department":["Microbiology, Parasitology, and Pathology Post Graduation Program, Department of Pathology"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Concei\u00e7\u00e3o de Maria Pedrozo e Silva de","family":"Azevedo","sequence":"additional","affiliation":[{"name":"Federal University of Maranh\u00e3o","place":["S\u00e3o Lu\u00eds, Maranh\u00e3o, Brazil"],"department":["Department of Medicine"]},{"name":"Federal University of Maranh\u00e3o","place":["S\u00e3o Lu\u00eds, Maranh\u00e3o, Brazil"],"department":["Post-graduation Program of Health Science"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,10,13]]},"reference":[{"issue":"1","key":"pntd.0014801.ref001","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1128\/CMR.00032-16","article-title":"Chromoblastomycosis","volume":"30","author":"F Queiroz-Telles","year":"2017","journal-title":"Clin Microbiol Rev"},{"issue":"11","key":"pntd.0014801.ref002","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005102","article-title":"Molecular epidemiology of agents of human chromoblastomycosis in Brazil with the description of two novel species","volume":"10","author":"RR Gomes","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"issue":"8","key":"pntd.0014801.ref003","article-title":"The global burden of chromoblastomycosis","volume":"15","author":"DWCL Santos","year":"2021","journal-title":"PLoS Negl Trop Dis"},{"key":"pntd.0014801.ref004","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.simyco.2017.01.001","article-title":"Exploring the genomic diversity of black yeasts and relatives (Chaetothyriales, Ascomycota)","volume":"86","author":"MM Teixeira","year":"2017","journal-title":"Stud Mycol"},{"key":"pntd.0014801.ref005","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.3389\/fmicb.2017.01924","article-title":"Comparative genomics of sibling species of Fonsecaea associated with human chromoblastomycosis","volume":"8","author":"VA Vicente","year":"2017","journal-title":"Front Microbiol"},{"key":"pntd.0014801.ref006","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s11046-012-9586-z","article-title":"Chromoblastomycosis in Mainland China: A systematic review on clinical characteristics","volume":"175","author":"S Lu","year":"2013","journal-title":"Mycopathologia"},{"issue":"5","key":"pntd.0014801.ref007","first-page":"312","article-title":"Histoire naturelle des chromoblastomycoses \u00e0 Madagascar et dans l\u2019Oc\u00e9an indien","volume":"90","author":"P Esterre","year":"1997","journal-title":"Bull Soc Pathol Exot"},{"issue":"1","key":"pntd.0014801.ref008","doi-asserted-by":"crossref","first-page":"14229","DOI":"10.1038\/s41598-020-70915-0","article-title":"Environmental prospecting of black yeast-like agents of human disease using culture-independent methodology","volume":"10","author":"FF Costa","year":"2020","journal-title":"Sci Rep"},{"issue":"4","key":"pntd.0014801.ref009","doi-asserted-by":"crossref","first-page":"122","DOI":"10.3390\/tropicalmed4040122","article-title":"The diagnosis of fungal neglected tropical diseases (fungal NTDs) and the role of investigation and laboratory tests: An expert consensus report","volume":"4","author":"R Hay","year":"2019","journal-title":"Trop Med Infect Dis"},{"issue":"12","key":"pntd.0014801.ref010","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/jac\/dkw325","article-title":"Global access to antifungal therapy and its variable cost","volume":"71","author":"M Kneale","year":"2016","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"pntd.0014801.ref011","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1353\/hpu.2016.0146","article-title":"The effectiveness of a multifocal training to improve the treatment of chromoblastomycosis in rural madagascar","volume":"27","author":"A Santmyire","year":"2016","journal-title":"J Health Care Poor Underserved"},{"issue":"9","key":"pntd.0014801.ref012","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005759","article-title":"Global health policy and neglected tropical diseases: Then, now, and in the years to come","volume":"11","author":"T F\u00fcrst","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"pntd.0014801.ref013","author":"World Health Organization","year":"2025"},{"issue":"2","key":"pntd.0014801.ref014","doi-asserted-by":"crossref","first-page":"423","DOI":"10.4269\/ajtmh.25-0051","article-title":"Chromoblastomycosis, phaeohyphomycotic abscess, and sporotrichosis among American Indian\/Alaska Natives, Indian Health Service, 2016\u20132022","volume":"113","author":"DJ Smith","year":"2025","journal-title":"Am J Trop Med Hyg"},{"issue":"10","key":"pntd.0014801.ref015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0012562","article-title":"A global chromoblastomycosis strategy and development of the global chromoblastomycosis working group","volume":"18","author":"DJ Smith","year":"2024","journal-title":"PLoS Negl Trop Dis"},{"key":"pntd.0014801.ref016","first-page":"101739","article-title":"Leveraging malaria microscopy infrastructure to diagnose common and neglected skin diseases using direct microscopy in Sumba, Indonesia","volume":"64","author":"GO Siregar","year":"2025","journal-title":"Lancet Reg Health West Pac"},{"issue":"7","key":"pntd.0014801.ref017","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1093\/ced\/llaf111","article-title":"Chromoblastomycosis: A case series from Sumba, eastern Indonesia","volume":"50","author":"GO Siregar","year":"2025","journal-title":"Clin Exp Dermatol"},{"issue":"2","key":"pntd.0014801.ref018","doi-asserted-by":"crossref","first-page":"364","DOI":"10.4269\/ajtmh.23-0218","article-title":"Teledermatology to improve access to and quality of skin care in eastern Indonesia","volume":"110","author":"FJ Adella","year":"2024","journal-title":"Am J Trop Med Hyg"},{"issue":"9","key":"pntd.0014801.ref019","doi-asserted-by":"crossref","DOI":"10.1111\/myc.13796","article-title":"Chromoblastomycosis: A single centre clinical laboratory experience of seven years (2016-2022) and literature review from Pakistan","volume":"67","author":"M Zeeshan","year":"2024","journal-title":"Mycoses"},{"issue":"1","key":"pntd.0014801.ref020","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1186\/s12879-025-11475-4","article-title":"Chromoblastomycosis in Peru: A retrospective review of 13 cases","volume":"25","author":"M Sanchez-Diaz","year":"2025","journal-title":"BMC Infect Dis"},{"issue":"5","key":"pntd.0014801.ref021","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1093\/ced\/llaf329","article-title":"Chromoblastomycosis in northern Taiwan from 2017 to 2024: Unique characteristics","volume":"51","author":"J-S Yen","year":"2026","journal-title":"Clin Exp Dermatol"},{"issue":"4","key":"pntd.0014801.ref022","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3314\/mmj.25-00018","article-title":"First Japanese case of chromoblastomycosis caused by Phialophora europaea","volume":"66","author":"C Okuyama","year":"2025","journal-title":"Med Mycol J"},{"issue":"3","key":"pntd.0014801.ref023","doi-asserted-by":"crossref","first-page":"349","DOI":"10.4067\/s0716-10182022000200349","article-title":"Cromoblastomicosis. Primer caso al\u00f3ctono tratado en Chile","volume":"39","author":"C Jahr","year":"2022","journal-title":"Rev Chil Infectol"},{"issue":"10","key":"pntd.0014801.ref024","doi-asserted-by":"crossref","DOI":"10.1002\/ccr3.9392","article-title":"Triple therapy approach for treating chromoblastomycosis in a Lebanese patient","volume":"12","author":"J Khodeir","year":"2024","journal-title":"Clin Case Rep"},{"key":"pntd.0014801.ref025","doi-asserted-by":"crossref","first-page":"100825","DOI":"10.1016\/j.ijmmb.2025.100825","article-title":"Expanding geographical niche of emerging pathogen Fonsecaea nubica: First report of its isolation from India from a case of chromoblastomycosis","volume":"55","author":"V Hallur","year":"2025","journal-title":"Indian J Med Microbiol"},{"key":"pntd.0014801.ref026","article-title":"A case of mycetoma-like chromoblastomycosis in Qatar","volume":"21","author":"GA Ali","year":"2020","journal-title":"IDCases"},{"issue":"1","key":"pntd.0014801.ref027","doi-asserted-by":"crossref","first-page":"117411","DOI":"10.1016\/j.diagmicrobio.2026.117411","article-title":"Chromoblastomycosis caused by Fonsecaea pedrosoi: The first molecularly confirmed case from T\u00fcrkiye","volume":"116","author":"B \u00c7al\u0131\u015f\u0131r","year":"2026","journal-title":"Diagn Microbiol Infect Dis"},{"key":"pntd.0014801.ref028","author":"Impact Global Health","year":"2025"},{"issue":"8","key":"pntd.0014801.ref029","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005534","article-title":"Chromoblastomycosis in India: Review of 169 cases","volume":"11","author":"R Agarwal","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"issue":"5","key":"pntd.0014801.ref030","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1001\/archderm.1997.03890410127025","article-title":"Chromoblastomycosis produced by Aureobasidium pullulans in an immunosuppressed patient","volume":"133","author":"P Redondo-Bell\u00f3n","year":"1997","journal-title":"Arch Dermatol"},{"issue":"2","key":"pntd.0014801.ref031","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1080\/13693780701630420","article-title":"A rare case of chromoblastomycosis in a renal transplant recipient caused by a non-sporulating species of Rhytidhysteron","volume":"46","author":"A Chowdhary","year":"2008","journal-title":"Medical Mycology"},{"issue":"5","key":"pntd.0014801.ref032","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1111\/j.1365-2133.2007.08091.x","article-title":"Chromoblastomycosis caused by Chaetomium funicola: A case report from Western Panama","volume":"157","author":"M Piepenbring","year":"2007","journal-title":"Br J Dermatol"},{"key":"pntd.0014801.ref033","doi-asserted-by":"crossref","first-page":"1396224","DOI":"10.3389\/fmed.2024.1396224","article-title":"Chromoblastomycosis caused by Alternaria infectoria, concurrent with myiasis, in a recipient of a kidney transplant: A compelling case report","volume":"11","author":"H Mahmoudi","year":"2024","journal-title":"Front Med (Lausanne)"},{"issue":"10","key":"pntd.0014801.ref034","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.3390\/microorganisms9102139","article-title":"Chromoblastomycosis due to a never-before-seen dematiaceous fungus in a kidney transplant patient","volume":"9","author":"H Guegan","year":"2021","journal-title":"Microorganisms"},{"issue":"6","key":"pntd.0014801.ref035","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/dth.12149","article-title":"Successful sequential treatment with itraconazole and ALA-PDT for chromoblastomycosis because of Alternaria alternata","volume":"27","author":"Z-H Liu","year":"2014","journal-title":"Dermatol Ther"},{"issue":"4","key":"pntd.0014801.ref036","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s11046-019-00359-2","article-title":"New molecular markers distinguishing Fonsecaea agents of chromoblastomycosis","volume":"184","author":"GX Schneider","year":"2019","journal-title":"Mycopathologia"},{"issue":"2","key":"pntd.0014801.ref037","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0171291","article-title":"Phylogenomic analyses reveal the diversity of laccase-coding genes in Fonsecaea genomes","volume":"12","author":"LF Moreno","year":"2017","journal-title":"PLoS One"},{"issue":"6","key":"pntd.0014801.ref038","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.3201\/eid2606.191498","article-title":"Endemic chromoblastomycosis caused predominantly by Fonsecaea nubica, Madagascar","volume":"26","author":"T Rasamoelina","year":"2020","journal-title":"Emerg Infect Dis"},{"issue":"4","key":"pntd.0014801.ref039","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s11046-026-01083-4","article-title":"Predominance of Fonsecaea nubica in chromoblastomycosis: A single-centre study from southern India","volume":"191","author":"J Nair","year":"2026","journal-title":"Mycopathologia"},{"key":"pntd.0014801.ref040","first-page":"87","article-title":"Cromoblastomicosis en M\u00e9xico. Revisi\u00f3n de 603 casos en siete d\u00e9cadas","volume":"12","author":"MR Navarrete","year":"2014","journal-title":"Dermatologia CMQ"},{"issue":"10","key":"pntd.0014801.ref041","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1111\/j.1749-6632.1950.tb39826.x","article-title":"Chromoblastomycosis","author":"AL Carrion","year":"1950","journal-title":"Ann N Y Acad Sci"},{"key":"pntd.0014801.ref042","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jdcr.2023.07.029","article-title":"An unusually subtle presentation of chromoblastomycosis","volume":"40","author":"WC Lau","year":"2023","journal-title":"JAAD Case Rep"},{"issue":"1","key":"pntd.0014801.ref043","doi-asserted-by":"crossref","first-page":"140","DOI":"10.4103\/idoj.idoj_182_21","article-title":"Unusual presentation of chromoblastomycosis with a brief review of its atypical cutaneous presentations","volume":"13","author":"N Pallivalappil","year":"2022","journal-title":"Indian Dermatol Online J"},{"issue":"2","key":"pntd.0014801.ref044","first-page":"83","article-title":"Chromoblastomycosis masquerading as palmo-plantar psoriasis","volume":"65","author":"TS Lakshmi","year":"1999","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"5","key":"pntd.0014801.ref045","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1111\/j.1365-4632.2011.05088.x","article-title":"Chromoblastomycosis presenting as a phagedenic ulcer on the face","volume":"51","author":"KN Naveen","year":"2012","journal-title":"Int J Dermatol"},{"issue":"4","key":"pntd.0014801.ref046","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.medmal.2017.09.011","article-title":"From phaeohyphomycosis to disseminated chromoblastomycosis: A retrospective study of infections caused by dematiaceous fungi","volume":"48","author":"E Thomas","year":"2018","journal-title":"Med Mal Infect"},{"issue":"8","key":"pntd.0014801.ref047","first-page":"32","article-title":"Revista Boliviana de Dermatolog\u00eda","volume":"5","author":"AY Escobar","year":"2015","journal-title":"Rev Bol Dermatol"},{"issue":"11","key":"pntd.0014801.ref048","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1111\/ijd.14185","article-title":"Chromoblastomycosis: Clinical experience and review of literature","volume":"57","author":"AJR Queir\u00f3z","year":"2018","journal-title":"Int J Dermatol"},{"issue":"6","key":"pntd.0014801.ref049","first-page":"423","article-title":"Wide morphologic variability of chromoblastomycosis in the western hemisphere","volume":"14","author":"BJ Mugleston","year":"2016","journal-title":"Skinmed"},{"issue":"5","key":"pntd.0014801.ref050","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmi.2016.12.024","article-title":"Melanized fungal infections in kidney transplant recipients: Contributions to optimize clinical management","volume":"23","author":"DW Santos","year":"2017","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"pntd.0014801.ref051","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/ijd.15948","article-title":"Therapeutic management of subcutaneous phaeohyphomycosis and chromoblastomycosis in kidney transplant recipients: A retrospective study of 82 cases in a single center","volume":"61","author":"SH Hirata","year":"2022","journal-title":"Int J Dermatol"},{"key":"pntd.0014801.ref052","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1001\/archderm.1942.01500070023002","article-title":"Chromoblastomycosis in Cuba","volume":"45","author":"V Pardo-Castello","year":"1942","journal-title":"Arch Dermatol Syphilograph"},{"issue":"4","key":"pntd.0014801.ref053","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1067\/mjd.2001.112220","article-title":"Chromoblastomycosis: A review of 100 cases in the state of Rio Grande do Sul, Brazil","volume":"44","author":"R Minotto","year":"2001","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"pntd.0014801.ref054","first-page":"614","article-title":"Association d\u2019un eumyc\u00e9tome et d\u2019une chromomycose: une observation au S\u00e9n\u00e9gal","volume":"63","author":"T Passeron","year":"2003","journal-title":"Med Trop (Mars)"},{"issue":"3","key":"pntd.0014801.ref055","first-page":"385","article-title":"Association d\u2019une chromoblastomycose \u00e0 Fonsecaea pedrosoi et d\u2019une histoplasmose \u00e0 Histoplasma capsulatum au Sud-Cameroun","volume":"66","author":"P Ravisse","year":"1973","journal-title":"Bull Soc Pathol Exot Filiales"},{"issue":"2","key":"pntd.0014801.ref056","first-page":"113","article-title":"Cromoblastomicose no Rio Grande do Sul","volume":"24","author":"NN Silva","year":"1949","journal-title":"Anais Brasileiros de Dermatologia e Sifilografia"},{"issue":"8","key":"pntd.0014801.ref057","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1111\/j.1365-4632.2010.04729.x","article-title":"Chromoblastomycosis: A clinical and molecular study of 18 cases in Rio de Janeiro, Brazil","volume":"50","author":"F Mde","year":"2011","journal-title":"Int J Dermatol"},{"issue":"1","key":"pntd.0014801.ref058","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S0151-9638(06)70849-3","article-title":"Chromomycose \u00e0 Exophiala spinifera en Afrique sah\u00e9lienne","volume":"133","author":"M Develoux","year":"2006","journal-title":"Ann Dermatol Venereol"},{"issue":"5","key":"pntd.0014801.ref059","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/j.1365-4362.1985.tb05789.x","article-title":"Chromomycosis in Zaire","volume":"24","author":"IS Banks","year":"1985","journal-title":"Int J Dermatol"},{"issue":"11","key":"pntd.0014801.ref060","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1111\/j.1365-4362.1992.tb04252.x","article-title":"Itraconazole in the treatment of chromoblastomycosis due to Fonsecaea pedrosoi","volume":"31","author":"F Queiroz-Telles","year":"1992","journal-title":"Int J Dermatol"},{"issue":"4","key":"pntd.0014801.ref061","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s11046-022-00646-5","article-title":"Chromoblastomycosis-leprosy co-infection in central West Brazil. Presentation of three cases and literature review","volume":"187","author":"A Guevara","year":"2022","journal-title":"Mycopathologia"},{"issue":"6","key":"pntd.0014801.ref062","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.jaad.2024.03.056","article-title":"Dermatologic fungal neglected tropical diseases-Part I. Epidemiology and clinical features","volume":"92","author":"KL Curtis","year":"2025","journal-title":"J Am Acad Dermatol"},{"issue":"10","key":"pntd.0014801.ref063","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0009774","article-title":"Communication in Neglected Tropical Diseases\u2019 elimination: A scoping review and call for action","volume":"16","author":"C Nieto-Sanchez","year":"2022","journal-title":"PLoS Negl Trop Dis"},{"issue":"2","key":"pntd.0014801.ref064","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.diagmicrobio.2019.05.018","article-title":"Mixed secondary bacterial infection is associated with severe lesions of chromoblastomycosis in a neglected population from Brazil","volume":"95","author":"SG Marques","year":"2019","journal-title":"Diagn Microbiol Infect Dis"},{"key":"pntd.0014801.ref065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1439-0507.2001.00613.x","article-title":"Chromoblastomycosis: Clinical and mycologic experience of 51 cases","volume":"44","author":"A Bonifaz","year":"2001","journal-title":"Mycoses"},{"issue":"4","key":"pntd.0014801.ref066","article-title":"Chromoblastomycosis in an endemic area of Brazil: A clinical-epidemiological analysis and a worldwide haplotype network","volume":"6","author":"DWCL Santos","year":"2020","journal-title":"J Fungi (Basel)"},{"issue":"8","key":"pntd.0014801.ref067","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1046\/j.1365-4362.2003.01814.x","article-title":"Lymphoscintigraphic analysis in chromoblastomycosis","volume":"42","author":"MM Ogawa","year":"2003","journal-title":"Int J Dermatol"},{"issue":"10","key":"pntd.0014801.ref068","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1093\/cid\/civ104","article-title":"Squamous cell carcinoma derived from chronic chromoblastomycosis in Brazil","volume":"60","author":"CM Azevedo","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"1","key":"pntd.0014801.ref069","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/s13149-017-0543-9","article-title":"Cancer et mycoses et revue de la litt\u00e9rature","volume":"110","author":"M Develoux","year":"2017","journal-title":"Bull Soc Pathol Exot"},{"key":"pntd.0014801.ref070","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s11046-014-9824-7","article-title":"Chromoblastomycosis by Cladophialophora carrionii associated with squamous cell carcinoma and review of published reports","volume":"179","author":"OC Rojas","year":"2015","journal-title":"Mycopathologia"},{"issue":"3","key":"pntd.0014801.ref071","doi-asserted-by":"crossref","first-page":"464","DOI":"10.3201\/eid1703.100555","article-title":"Molecular epidemiology of Fonsecaea species","volume":"17","author":"MJ Najafzadeh","year":"2011","journal-title":"Emerg Infect Dis"},{"key":"pntd.0014801.ref072","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3114\/sim.2007.58.08","article-title":"Molecular analysis and pathogenicity of the Cladophialophora carrionii complex, with the description of a novel species","volume":"58","author":"GS de Hoog","year":"2007","journal-title":"Stud Mycol"},{"issue":"8","key":"pntd.0014801.ref073","doi-asserted-by":"crossref","first-page":"548","DOI":"10.3390\/jof10080548","article-title":"Development of PCR-multiplex assays for identification of the Herpotrichiellaceae family and agents causing chromoblastomycosis","volume":"10","author":"GSM Sousa","year":"2024","journal-title":"J Fungi (Basel)"},{"issue":"4","key":"pntd.0014801.ref074","doi-asserted-by":"crossref","first-page":"382","DOI":"10.3390\/jof8040382","article-title":"Molecular diagnosis of two major implantation mycoses: Chromoblastomycosis and sporotrichosis","volume":"8","author":"D Maubon","year":"2022","journal-title":"J Fungi (Basel)"},{"issue":"1","key":"pntd.0014801.ref075","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.mimet.2009.10.002","article-title":"Rapid detection of pathogenic fungi using loop-mediated isothermal amplification, exemplified by Fonsecaea agents of chromoblastomycosis","volume":"80","author":"J Sun","year":"2010","journal-title":"J Microbiol Methods"},{"issue":"10","key":"pntd.0014801.ref076","doi-asserted-by":"crossref","first-page":"3531","DOI":"10.1128\/JCM.01033-14","article-title":"Three isothermal amplification techniques for rapid identification of Cladophialophora carrionii, an agent of human chromoblastomycosis","volume":"52","author":"S Deng","year":"2014","journal-title":"J Clin Microbiol"},{"issue":"4","key":"pntd.0014801.ref077","doi-asserted-by":"crossref","first-page":"290","DOI":"10.3390\/jof6040290","article-title":"Environmental screening of Fonsecaea agents of chromoblastomycosis using rolling circle amplification","volume":"6","author":"MF Voidaleski","year":"2020","journal-title":"J Fungi (Basel)"},{"issue":"5","key":"pntd.0014801.ref078","doi-asserted-by":"crossref","DOI":"10.1111\/j.1439-0507.2010.01995.x","article-title":"Rapid identification of fungal pathogens by rolling circle amplification using Fonsecaea as a model","volume":"54","author":"MJ Najafzadeh","year":"2011","journal-title":"Mycoses"},{"issue":"4","key":"pntd.0014801.ref079","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1080\/02681219880000371","article-title":"In vitro evaluation of terbinafine and itraconazole against dematiaceous fungi","volume":"36","author":"MR McGinnis","year":"1998","journal-title":"Med Mycol"},{"issue":"6","key":"pntd.0014801.ref080","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1046\/j.1365-280X.1999.00245.x","article-title":"In vitro susceptibility of chromoblastomycosis and phaeohyphomycosis agents to antifungal drugs","volume":"37","author":"RB Caligiorne","year":"1999","journal-title":"Med Mycol"},{"issue":"4","key":"pntd.0014801.ref081","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1128\/AAC.01655-09","article-title":"In vitro activities of eight antifungal drugs against 55 clinical isolates of Fonsecaea spp","volume":"54","author":"MJ Najafzadeh","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"pntd.0014801.ref082","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1080\/13693780802566333","article-title":"In vitro activity of antifungal drugs against Cladophialophora species associated with human chromoblastomycosis","volume":"47","author":"RG Vitale","year":"2009","journal-title":"Med Mycol"},{"issue":"4","key":"pntd.0014801.ref083","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1128\/AAC.02114-12","article-title":"In vitro antifungal susceptibility of Cladophialophora carrionii, an agent of human chromoblastomycosis","volume":"57","author":"S Deng","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"pntd.0014801.ref084","doi-asserted-by":"crossref","first-page":"5609","DOI":"10.1128\/AAC.02875-14","article-title":"In vitro activities of nine antifungal drugs and their combinations against Phialophora verrucosa","volume":"58","author":"Y Li","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"pntd.0014801.ref085","doi-asserted-by":"crossref","first-page":"6044","DOI":"10.1128\/AAC.01112-12","article-title":"In vitro activities of nine antifungal drugs against 81 Phialophora and Cyphellophora isolates","volume":"56","author":"P Feng","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"pntd.0014801.ref086","doi-asserted-by":"crossref","DOI":"10.1128\/jcm.01903-24","article-title":"Establishment of epidemiological cutoff values for Fonsecaea pedrosoi, the primary etiologic agent of chromoblastomycosis, and eight antifungal medications","volume":"63","author":"DJ Smith","year":"2025","journal-title":"J Clin Microbiol"},{"key":"pntd.0014801.ref087","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jgar.2018.09.010","article-title":"In vitro susceptibility of chromoblastomycosis agents to antifungal drugs: A systematic review","volume":"16","author":"AH da Silva Hellwig","year":"2019","journal-title":"J Glob Antimicrob Resist"},{"issue":"3","key":"pntd.0014801.ref088","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/1348-0421.70038","article-title":"In vitro activities of five antifungal drugs against conidia and sclerotic cells of chromoblastomycosis agent Fonsecaea spp","volume":"70","author":"AB Takahashi","year":"2026","journal-title":"Microbiol Immunol"},{"issue":"2","key":"pntd.0014801.ref089","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/BF01103608","article-title":"Hyperthermic treatment of chromomycosis with disposable chemical pocket warmers. Report of a successfully treated case, with a review of the literature","volume":"122","author":"M Hiruma","year":"1993","journal-title":"Mycopathologia"},{"issue":"4","key":"pntd.0014801.ref090","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0190-9622(84)80266-2","article-title":"Successful treatment of chromoblastomycosis with topical heat therapy","volume":"10","author":"H Tagami","year":"1984","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"pntd.0014801.ref091","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1365-4632.2009.03744.x","article-title":"Chromoblastomycosis: Combined treatment with pulsed itraconazole therapy and liquid nitrogen cryotherapy","volume":"48","author":"RR Ranawaka","year":"2009","journal-title":"Int J Dermatol"},{"issue":"4","key":"pntd.0014801.ref092","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1365-4362.1983.tb03371.x","article-title":"Chromomycosis in Japan","volume":"22","author":"R Fukushiro","year":"1983","journal-title":"Int J Dermatol"},{"issue":"3","key":"pntd.0014801.ref093","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1439-0507.2005.01089.x","article-title":"A case of chromomycosis caused by Fonsecaea pedrosoi and a review of reported cases of dematiaceous fungal infection in Japan","volume":"48","author":"M Kondo","year":"2005","journal-title":"Mycoses"},{"issue":"5","key":"pntd.0014801.ref094","article-title":"Photodynamic therapy for pathogenic fungi","volume":"54","author":"JP Lyon","year":"2011","journal-title":"Mycoses"},{"issue":"2","key":"pntd.0014801.ref095","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1007\/s42770-023-00974-8","article-title":"New methylene blue-mediated photodynamic inactivation of multidrug-resistant Fonsecaea nubica infected chromoblastomycosis in vitro","volume":"54","author":"M Zheng","year":"2023","journal-title":"Braz J Microbiol"},{"issue":"1","key":"pntd.0014801.ref096","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1080\/21501203.2024.2383640","article-title":"Improving treatment of chromoblastomycosis: The potential of COP1T-HA and antimicrobial photodynamic therapy against Fonsecaea monophora in vitro","volume":"16","author":"X Liu","year":"2024","journal-title":"Mycology"},{"key":"pntd.0014801.ref097","doi-asserted-by":"crossref","first-page":"104255","DOI":"10.1016\/j.pdpdt.2024.104255","article-title":"Potassium iodide enhances the killing effect of methylene blue mediated photodynamic therapy against F. monophora","volume":"48","author":"Q Li","year":"2024","journal-title":"Photodiagnosis Photodyn Ther"},{"issue":"4","key":"pntd.0014801.ref098","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s11046-011-9434-6","article-title":"Photodynamic antifungal therapy against chromoblastomycosis","volume":"172","author":"JP Lyon","year":"2011","journal-title":"Mycopathologia"},{"issue":"6","key":"pntd.0014801.ref099","doi-asserted-by":"crossref","first-page":"649","DOI":"10.3109\/13693786.2012.655258","article-title":"A refractory case of chromoblastomycosis due to Fonsecaea monophora with improvement by photodynamic therapy","volume":"50","author":"Y Yang","year":"2012","journal-title":"Med Mycol"},{"key":"pntd.0014801.ref100","doi-asserted-by":"crossref","first-page":"105447","DOI":"10.1016\/j.pdpdt.2026.105447","article-title":"A case of skin chromoblastomycosis caused by Fonsecaea monophora treated with itraconazole and photodynamic therapy","volume":"58","author":"J Chen","year":"2026","journal-title":"Photodiagnosis Photodyn Ther"},{"key":"pntd.0014801.ref101","doi-asserted-by":"crossref","first-page":"101589","DOI":"10.1016\/j.pdpdt.2019.101589","article-title":"5-aminolevulinic acid-based photodynamic therapy associated with Itraconazole successfully treated a case of chromoblastomycosis","volume":"29","author":"W Yang","year":"2020","journal-title":"Photodiagnosis Photodyn Ther"},{"key":"pntd.0014801.ref102","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.pdpdt.2019.02.013","article-title":"Successful treatment of chromoblastomycosis using ALA-PDT in a patient with leukopenia","volume":"26","author":"X Huang","year":"2019","journal-title":"Photodiagnosis Photodyn Ther"},{"issue":"10","key":"pntd.0014801.ref103","article-title":"Photodynamic therapy combined with antifungal drugs against chromoblastomycosis and the effect of ALA-PDT on Fonsecaea in vitro","volume":"13","author":"Y Hu","year":"2019","journal-title":"PLoS Negl Trop Dis"},{"issue":"5","key":"pntd.0014801.ref104","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1001\/archderm.1971.04000230018003","article-title":"Chromomycosis. Treatment with thiabendazole","volume":"104","author":"MA Bayles","year":"1971","journal-title":"Arch Dermatol"},{"key":"pntd.0014801.ref105","first-page":"1335","article-title":"Tratamento da cromomicose pela 5-fluorocitosina. Primeiros resultados","volume":"75","author":"CF Lopes","year":"1969","journal-title":"Hospital (Rio)"},{"issue":"5","key":"pntd.0014801.ref106","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/ijd.1978.17.5.414","article-title":"Six years\u2019 experience in treatment of chromomycosis with 5-fluorocytosine,","volume":"17","author":"CF Lopes","year":"1978","journal-title":"Int J Dermatol"},{"key":"pntd.0014801.ref107","first-page":"125","article-title":"Treatment of chromoblastomycosis with 5-fluorocytosine","volume":"12","author":"CF Magalhaes","year":"1970","journal-title":"Int J Dermatol"},{"key":"pntd.0014801.ref108","article-title":"Itraconazole for deep mycoses: Preliminary experience in Mexico","author":"P Lavalle","year":"1987","journal-title":"Rev Infect Dis"},{"key":"pntd.0014801.ref109","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/j.1749-6632.1988.tb40448.x","article-title":"Treatment of chromoblastomycosis with itraconazole","volume":"544","author":"A Restrepo","year":"1988","journal-title":"Ann N Y Acad Sci"},{"issue":"2","key":"pntd.0014801.ref110","first-page":"172","article-title":"Chromoblastomycosis in the Amazon region, Brazil, caused by Fonsecaea pedrosoi, Fonsecaea nubica, and Rhinocladiella similis: Clinicopathology, susceptibility, and molecular identification","volume":"58","author":"TS de Andrade","year":"2020","journal-title":"Med Mycol"},{"issue":"11","key":"pntd.0014801.ref111","doi-asserted-by":"crossref","DOI":"10.1093\/mmy\/myac086","article-title":"Treatment responses in patients with chromoblastomycosis to itraconazole in Madagascar","volume":"60","author":"FA Sendrasoa","year":"2022","journal-title":"Med Mycol"},{"issue":"5","key":"pntd.0014801.ref112","first-page":"312","article-title":"Histoire naturelle des chromoblastomycoses \u00e0 Madagascar et dans l\u2019oc\u00e9an indien","volume":"90","author":"P Esterre","year":"1997","journal-title":"Bull Soc Pathol Exot"},{"key":"pntd.0014801.ref113","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1365-2133.1996.tb15658.x","article-title":"Treatment of chromomycosis with terbinafine: Preliminary results of an open pilot study","author":"P Esterre","year":"1996","journal-title":"Br J Dermatol"},{"issue":"1","key":"pntd.0014801.ref114","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1080\/09546630410024538","article-title":"Treatment of chromoblastomycosis with terbinafine: Experience with four cases","volume":"16","author":"A Bonifaz","year":"2005","journal-title":"J Dermatolog Treat"},{"issue":"2","key":"pntd.0014801.ref115","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1080\/09546630510033203","article-title":"Treatment of chromoblastomycosis with terbinafine: A report of four cases","volume":"16","author":"Z Xibao","year":"2005","journal-title":"J Dermatolog Treat"},{"issue":"2","key":"pntd.0014801.ref116","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.trstmh.2009.05.016","article-title":"Chromoblastomycosis in Sarawak, East Malaysian Borneo","volume":"104","author":"FBB Yap","year":"2010","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"12","key":"pntd.0014801.ref117","doi-asserted-by":"crossref","DOI":"10.1016\/j.annder.2015.10.426","article-title":"Chromomycose cutan\u00e9e: trois nouveaux cas marocains","volume":"142","author":"W Labbardi","year":"2015","journal-title":"Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"},{"issue":"6","key":"pntd.0014801.ref118","doi-asserted-by":"crossref","first-page":"437","DOI":"10.4103\/ijp.ijp_397_24","article-title":"Chromoblastomycosis is curable with DAT therapy (debulking, intralesional amphotericin B, oral terbinafine); case series of 16 patients","volume":"56","author":"RR Ranawaka","year":"2024","journal-title":"Indian J Pharmacol"},{"issue":"3","key":"pntd.0014801.ref119","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3314\/mmj.52.255","article-title":"Chromoblastomycosis caused by Fonsecaea monophora","volume":"52","author":"Y Sugiyama","year":"2011","journal-title":"Med Mycol J"},{"issue":"3","key":"pntd.0014801.ref120","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3109\/09546630903585074","article-title":"Extensive long-standing chromomycosis due to Fonsecaea pedrosoi: Three cases with relevant improvement under voriconazole therapy","volume":"22","author":"PR Criado","year":"2011","journal-title":"J Dermatolog Treat"},{"issue":"5","key":"pntd.0014801.ref121","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/1756-185X.12450","article-title":"A case of chromoblastomycosis caused by Fonsecaea pedrosoi in a patient with rheumatoid arthritis","volume":"18","author":"T Ohashi","year":"2015","journal-title":"Int J Rheum Dis"},{"issue":"5","key":"pntd.0014801.ref122","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1590\/abd1806-4841.20165142","article-title":"Response of chromoblastomycosis to voriconazole","volume":"91","author":"AMde Lima","year":"2016","journal-title":"An Bras Dermatol"},{"issue":"1","key":"pntd.0014801.ref123","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/ced.13279","article-title":"Longitudinal melanonychia due to voriconazole therapy during treatment of chromoblastomycosis","volume":"43","author":"PR Criado","year":"2018","journal-title":"Clin Exp Dermatol"},{"issue":"9","key":"pntd.0014801.ref124","article-title":"Concurrent chromoblastomycosis and eumycetoma: A unique case of dual neglected tropical fungal diseases in Asia","volume":"19","author":"W Liu","year":"2025","journal-title":"PLoS Negl Trop Dis"},{"issue":"6","key":"pntd.0014801.ref125","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1590\/S0036-46652005000600006","article-title":"Posaconazole treatment of refractory eumycetoma and chromoblastomycosis","volume":"47","author":"R Negroni","year":"2005","journal-title":"Rev Inst Med Trop Sao Paulo"},{"issue":"2","key":"pntd.0014801.ref126","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1399-3062.2009.00477.x","article-title":"Unusual presentation of chromoblastomycosis due to Cladophialophora carrionii in a renal and pancreas transplant recipient patient successfully treated with posaconazole and surgical excision","volume":"12","author":"C Dupont","year":"2010","journal-title":"Transpl Infect Dis"},{"issue":"4","key":"pntd.0014801.ref127","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofad124","article-title":"Chromoblastomycosis treated with posaconazole and adjunctive imiquimod: Lending innate immunity a helping hand","volume":"10","author":"C Logan","year":"2023","journal-title":"Open Forum Infect Dis"},{"key":"pntd.0014801.ref128","doi-asserted-by":"crossref","DOI":"10.25259\/IJDVL_1061_2023","article-title":"Refractory and disfiguring facial chromoblastomycosis caused by Exophiala spinifera responsive to posaconazole in an immunocompetent patient","volume":"91","author":"IS Reddy","year":"2025","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"4","key":"pntd.0014801.ref129","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.micinf.2005.01.006","article-title":"Cytokines and lymphocyte proliferation in patients with different clinical forms of chromoblastomycosis","volume":"7","author":"V Mazo F\u00e1vero Gimenes","year":"2005","journal-title":"Microbes Infect"},{"issue":"4","key":"pntd.0014801.ref130","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.1439-0507.2007.01485.x","article-title":"The use of glucan as immunostimulant in the treatment of a severe case of chromoblastomycosis","volume":"51","author":"SG Marques","year":"2008","journal-title":"Mycoses"},{"key":"pntd.0014801.ref131","first-page":"443","article-title":"The role of glucan in the prevention and modification of microparasitic diseases","volume":"161","author":"NR Di Luzio","year":"1984","journal-title":"Prog Clin Biol Res"},{"issue":"5","key":"pntd.0014801.ref132","doi-asserted-by":"crossref","first-page":"496","DOI":"10.4269\/ajtmh.1996.55.496","article-title":"The use of glucan as immunostimulant in the treatment of paracoccidioidomycosis","volume":"55","author":"DA Meira","year":"1996","journal-title":"Am J Trop Med Hyg"},{"issue":"12","key":"pntd.0014801.ref133","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1093\/cid\/ciu168","article-title":"Topical application of imiquimod as a treatment for chromoblastomycosis","volume":"58","author":"GT de Sousa M da","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"4","key":"pntd.0014801.ref134","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/1346-8138.15225","article-title":"Successful treatment of chromoblastomycosis caused by Fonsecaea pedrosoi using imiquimod","volume":"47","author":"Jr Belda W","year":"2020","journal-title":"J Dermatol"},{"issue":"6","key":"pntd.0014801.ref135","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.4269\/ajtmh.21-0735","article-title":"Case report: Short-term application of topical imiquimod is practical for chromoblastomycosis","volume":"105","author":"XW Huang","year":"2021","journal-title":"Am J Trop Med Hyg"},{"key":"pntd.0014801.ref136","doi-asserted-by":"crossref","first-page":"106045","DOI":"10.1016\/j.intimp.2019.106045","article-title":"Acitretin inhibits IL-17A-induced IL-36 expression in keratinocytes by down-regulating I\u03baB\u03b6","volume":"79","author":"J Tu","year":"2020","journal-title":"Int Immunopharmacol"},{"issue":"5","key":"pntd.0014801.ref137","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.4269\/ajtmh.20-0471","article-title":"Case report: Treatment of chromoblastomycosis with combinations including acitretin: A report of two cases","volume":"103","author":"W Belda","year":"2020","journal-title":"Am J Trop Med Hyg"},{"issue":"4","key":"pntd.0014801.ref138","doi-asserted-by":"crossref","first-page":"162","DOI":"10.3390\/diseases11040162","article-title":"Chromoblastomycosis: New perspective on adjuvant treatment with acitretin","volume":"11","author":"Jr Belda W","year":"2023","journal-title":"Diseases"},{"key":"pntd.0014801.ref139","author":"Impact Global Health","year":"2025"},{"issue":"6","key":"pntd.0014801.ref140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0011443","article-title":"Diagnostic capacities and treatment practices on implantation mycoses: Results from the 2022 WHO global online survey","volume":"17","author":"B Milani","year":"2023","journal-title":"PLoS Negl Trop Dis"},{"issue":"7","key":"pntd.0014801.ref141","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0013194","article-title":"Tracking progress along the WHO Neglected Tropical Diseases Road Map to 2030: A guide to the Gap Assessment Tool (GAT) and results from the 2023-2024 assessment","volume":"19","author":"M Donadeu","year":"2025","journal-title":"PLoS Negl Trop Dis"}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0014801","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T17:33:18Z","timestamp":1791912798000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0014801"}},"subtitle":[],"editor":[{"given":"Georgios","family":"Pappas","sequence":"first","affiliation":[{"name":"Institute of Continuing Medical Education of Ioannina","place":["GREECE"]}],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,10,13]]},"references-count":141,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,10,13]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0014801","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,13]]}}}